Selective light-triggered release of DNA from gold nanorods switches blood clotting on and off
Files
(Published version)
Date
2013
Authors
de Puig, H.
Cifuentes, R.A.
Flemister, D.
Baxamusa, S.H.
Hamad Schifferli, K.
Editors
Antopolsky, M.
Advisors
Journal Title
Journal ISSN
Volume Title
Type:
Journal article
Citation
PLoS ONE, 2013; 8(7, article no. e68511):1-6
Statement of Responsibility
Conference Name
Abstract
Blood clotting is a precise cascade engineered to form a clot with temporal and spatial control. Current control of blood clotting is achieved predominantly by anticoagulants and thus inherently one-sided. Here we use a pair of nanorods (NRs) to provide a two-way switch for the blood clotting cascade by utilizing their ability to selectively release species on their surface under two different laser excitations. We selectively trigger release of a thrombin binding aptamer from one nanorod, inhibiting blood clotting and resulting in increased clotting time. We then release the complementary DNA as an antidote from the other NR, reversing the effect of the aptamer and restoring blood clotting. Thus, the nanorod pair acts as an on/off switch. One challenge for nanobiotechnology is the bio-nano interface, where coronas of weakly adsorbed proteins can obscure biomolecular function. We exploit these adsorbed proteins to increase aptamer and antidote loading on the nanorods.
School/Discipline
Dissertation Note
Provenance
Description
Access Status
Rights
Copyright 2013 The Authors. This is an open-access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.